ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
5.11
+0.23 (4.72%)
Nov 21, 2024, 1:24 PM EST - Market open

ImmunityBio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Cash & Equivalents
111.97265.45104.64181.134.9260.29
Upgrade
Short-Term Investments
18.41.012.54136.0261.154.06
Upgrade
Cash & Short-Term Investments
130.37266.46107.18317.1296.0664.35
Upgrade
Cash Growth
-31.31%148.60%-66.20%230.12%49.28%-21.67%
Upgrade
Other Receivables
0.733.171.891.3328.67
Upgrade
Receivables
4.93.171.891.3328.67
Upgrade
Inventory
1.96-2.16---
Upgrade
Prepaid Expenses
15.2112.8714.7412.2513.652.54
Upgrade
Other Current Assets
10.7111.5914.63.65-1.12
Upgrade
Total Current Assets
163.15294.08140.58334.35111.7176.68
Upgrade
Property, Plant & Equipment
174.23182.68189.58119.1790.6827.78
Upgrade
Long-Term Investments
-0.890.847.611.4-
Upgrade
Other Intangible Assets
15.5717.09201.421.4612.07
Upgrade
Other Long-Term Assets
3.642.824.73--1.13
Upgrade
Total Assets
364.57504.45362.36468.91221.38123.54
Upgrade
Accounts Payable
9.959.221.0211.4211.517.05
Upgrade
Accrued Expenses
39.739.5334.2333.9433.9917.98
Upgrade
Short-Term Debt
2.161.48433.32301.83--
Upgrade
Current Portion of Leases
7.035.312.733.015.02-
Upgrade
Current Unearned Revenue
-----0.5
Upgrade
Other Current Liabilities
2.122.779.5718.817.6210.99
Upgrade
Total Current Liabilities
60.9658.28500.8636968.1336.52
Upgrade
Long-Term Debt
972.78836.95241.27306.35254.35181.62
Upgrade
Long-Term Leases
36.7639.9448.0237.0716.18-
Upgrade
Long-Term Deferred Tax Liabilities
----0.173.11
Upgrade
Other Long-Term Liabilities
38.24155.2122.030.411.045.18
Upgrade
Total Liabilities
1,1091,090812.18712.82339.87226.42
Upgrade
Common Stock
0.070.070.040.040.040.06
Upgrade
Additional Paid-In Capital
2,5712,3751,9311,7201,495623
Upgrade
Retained Earnings
-3,316-2,962-2,378-1,962-1,615-729.62
Upgrade
Comprehensive Income & Other
0.10.010.1800.120.02
Upgrade
Total Common Equity
-745.15-586.99-447.33-242.17-119.81-106.54
Upgrade
Minority Interest
0.991.05-2.49-1.741.323.65
Upgrade
Shareholders' Equity
-744.16-585.94-449.82-243.91-118.49-102.88
Upgrade
Total Liabilities & Equity
364.57504.45362.36468.91221.38123.54
Upgrade
Total Debt
1,019883.68725.33648.26275.55181.62
Upgrade
Net Cash (Debt)
-888.37-616.32-617.31-330.32-178.54-117.27
Upgrade
Net Cash Per Share
-1.30-1.21-1.54-0.85-0.47-0.32
Upgrade
Filing Date Shares Outstanding
696.83673.95435.84397.91333.96333.96
Upgrade
Total Common Shares Outstanding
696.83670.87421.57397.83333.96333.96
Upgrade
Working Capital
102.19235.8-360.28-34.6543.5840.16
Upgrade
Book Value Per Share
-1.07-0.87-1.06-0.61-0.36-0.32
Upgrade
Tangible Book Value
-761.63-604.08-467.33-243.59-121.27-118.61
Upgrade
Tangible Book Value Per Share
-1.09-0.90-1.11-0.61-0.36-0.36
Upgrade
Buildings
----22.693.41
Upgrade
Machinery
75.4871.869.8555.3435.7514.68
Upgrade
Construction In Progress
85.7284.4472.6916.581.331.33
Upgrade
Leasehold Improvements
72.5772.5568.7162.4852.2517.91
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.